Avidity Biosciences, Inc. Common Stock
Symbol: RNA (NASDAQ)
44.90
▲ (9.40%) 3.856
Company Description:
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Key Stats
- Today's Open: $43.06
- Today's High: $46.174
- Today's Low: $40.644
- Today's Volume: 12.96M
- Yesterday Close: $41.04
- Yesterday High: $41.59
- Yesterday Low: $35.7001
- Yesterday Volume: 11.33M
- Last Min Volume: 0
- Last Min High: $44.983
- Last Min Low: $44.896
- Last Min VWAP: $0
Company Profile
- Name: Avidity Biosciences, Inc. Common Stock
- Website: https://www.aviditybiosciences.com
- Listed Date: 2020-06-12
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001599901
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.76B
- Round Lot: 100
- Outstanding Shares: 128.65M
- Asset Type: CS
RECENT FILINGS FOR RNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | 8-K | View |
| 2025-09-12 | 424B5 | View |
| 2025-09-12 | 4 | View |
| 2025-09-11 | 144 | View |
| 2025-09-10 | 424B5 | View |
| 2025-09-10 | 8-K | View |
| 2025-09-09 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-05 | 144 | View |
| 2025-09-03 | 144 | View |
| 2025-09-02 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-28 | 144 | View |
| 2025-08-22 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
Latest News on RNA